|
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker (2009) |
- Sadr-Nabavi, A.,
- Ramser, J.,
- Volkmann, J.,
- Naehrig, J.,
- Wiesmann, F.,
- Betz, B.,
- Hellebrand, H.,
- Engert, S.,
- Seitz, S.,
- Kreutzfeld, R.,
- Sasaki, T.,
- Arnold, N.,
- Schmutzler, R.,
- Kiechle, M.,
- Niederacher, D.,
- Harbeck, N.,
- Dahl, E.,
- Meindl, A.
|
Publication details |
|